Table: Aska Pharmaceutical - 9-MTH group results

ASKA Pharmaceutical Holdings

05/02/2018 06:00

Feb 5 (Reuters)-  
             Aska Pharmaceutical Co Ltd  
             CONSOLIDATED FINANCIAL HIGHLIGHTS  
     (in billions of yen unless specified)                 
                 9 months ended      9 months ended       Year to  
                Dec 31, 2017        Dec 31, 2016     Mar 31, 2018  
                   LATEST             YEAR-AGO          LATEST     
                   RESULTS             RESULTS         FORECAST    
  Sales             38.71               37.48            50.00     
                 (+3.3 pct)          (+11.8 pct)      (+3.0 pct)   
  Operating          3.46                1.98             3.00     
                 (+75.2 pct)         (+20.3 pct)      (+67.3 pct)  
  Recurring          3.69                2.20             3.20     
                 (+68.1 pct)         (+19.5 pct)      (+59.8 pct)  
  Net                3.03                3.91             2.60     
                 (-22.6 pct)        (+262.0 pct)      (-11.7 pct)  
  EPS            107.46 yen          139.99 yen        92.23 yen   
  Ann Div                             14.00 yen        14.00 yen   
  -Q2 div         7.00 yen            7.00 yen                     
  -Q4 div                             7.00 yen         7.00 yen    
   
  NOTE - Aska Pharmaceutical Co Ltd.  
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4514.T 
  ((Tokyo Headline News Desk +813 6441 1812))